
TY  - JOUR
AU  - Hawiger, J.
AU  - Veach, R. A.
AU  - Zienkiewicz, J.
TI  - New paradigms in sepsis: from prevention to protection of failing microcirculation
JO  - Journal of Thrombosis and Haemostasis
JA  - J Thromb Haemost
VL  - 13
IS  - 10
SN  - 1538-7933
UR  - https://doi.org/10.1111/jth.13061
DO  - doi:10.1111/jth.13061
SP  - 1743
EP  - 1756
KW  - genome
KW  - infection
KW  - inflammation
KW  - microcirculation
KW  - septic shock
PY  - 2015
AB  - Summary Sepsis, also known as septicemia, is one of the 10 leading causes of death worldwide. The rising tide of sepsis due to bacterial, fungal and viral infections cannot be stemmed by current antimicrobial therapies and supportive measures. New paradigms for the mechanism and resolution of sepsis and consequences for sepsis survivors are emerging. Consistent with Benjamin Franklin's dictum ?an ounce of prevention is worth a pound of cure?, sepsis can be prevented by vaccinations against pneumococci and meningococci. Recently, the NIH NHLBI Panel redefined sepsis as ?severe endothelial dysfunction syndrome in response to intravascular and extravascular infections causing reversible or irreversible injury to the microcirculation responsible for multiple organ failure?. Microvascular endothelial injury underlies sepsis-associated hypotension, edema, disseminated intravascular coagulation, acute respiratory distress syndrome and acute kidney injury. Microbial genome products trigger ?genome wars? in sepsis that reprogram the human genome and culminate in a ?genomic storm? in blood and vascular cells. Sepsis can be averted experimentally by endothelial cytoprotection through targeting nuclear signaling that mediates inflammation and deranged metabolism. Endothelial ?rheostats? (e.g. inhibitors of NF-?B, A20 protein, CRADD/RAIDD protein and microRNAs) regulate endothelial signaling. Physiologic ?extinguishers? (e.g. suppressor of cytokine signaling 3) can be replenished through intracellular protein therapy. Lipid mediators (e.g. resolvin D1) hasten sepsis resolution. As sepsis cases rose from 387 330 in 1996 to 1.1 million in 2011, and are estimated to reach 2 million by 2020 in the US, mortality due to sepsis approaches that of heart attacks and exceeds deaths from stroke. More preventive vaccines and therapeutic measures are urgently needed.
ER  - 

TY  - JOUR
TI  - British Society for Matrix Biology – Spring 2012 Meeting Report
JO  - International Journal of Experimental Pathology
JA  - Int. J. Exp. Path.
VL  - 94
IS  - 1
SN  - 0959-9673
UR  - https://doi.org/10.1111/iep.12004
DO  - doi:10.1111/iep.12004
SP  - A1
EP  - A48
PY  - 2013
ER  - 

TY  - JOUR
TI  - Neuropathology (90)
JO  - Pathology International
VL  - 57
IS  - s1
SN  - 1320-5463
UR  - https://doi.org/10.1111/j.1440-1827.2007.02113_11.x
DO  - doi:10.1111/j.1440-1827.2007.02113_11.x
SP  - A26
EP  - A27
PY  - 2007
ER  - 

TY  - JOUR
TI  - Renal Pathology (117–118)
JO  - Pathology International
VL  - 57
IS  - s1
SN  - 1320-5463
UR  - https://doi.org/10.1111/j.1440-1827.2007.02113_14.x
DO  - doi:10.1111/j.1440-1827.2007.02113_14.x
SP  - A35
EP  - A35
PY  - 2007
ER  - 

TY  - JOUR
TI  - Urologic Pathology (119–127)
JO  - Pathology International
VL  - 57
IS  - s1
SN  - 1320-5463
UR  - https://doi.org/10.1111/j.1440-1827.2007.02113_15.x
DO  - doi:10.1111/j.1440-1827.2007.02113_15.x
SP  - A35
EP  - A38
PY  - 2007
ER  - 

TY  - JOUR
TI  - Hematolymphoid Pathology (63–78)
JO  - Pathology International
VL  - 57
IS  - s1
SN  - 1320-5463
UR  - https://doi.org/10.1111/j.1440-1827.2007.02113_7.x
DO  - doi:10.1111/j.1440-1827.2007.02113_7.x
SP  - A19
EP  - A23
PY  - 2007
ER  - 

TY  - JOUR
TI  - Bone and Soft Tissue Pathology (1–6)
JO  - Pathology International
VL  - 57
IS  - s1
SN  - 1320-5463
UR  - https://doi.org/10.1111/j.1440-1827.2007.02113_1.x
DO  - doi:10.1111/j.1440-1827.2007.02113_1.x
SP  - A1
EP  - A2
PY  - 2007
ER  - 

TY  - JOUR
TI  - Gynecologic Pathology (58–62)
JO  - Pathology International
VL  - 57
IS  - s1
SN  - 1320-5463
UR  - https://doi.org/10.1111/j.1440-1827.2007.02113_6.x
DO  - doi:10.1111/j.1440-1827.2007.02113_6.x
SP  - A17
EP  - A18
PY  - 2007
ER  - 

TY  - JOUR
TI  - Hepatobiliary Pathology (79–82)
JO  - Pathology International
VL  - 57
IS  - s1
SN  - 1320-5463
UR  - https://doi.org/10.1111/j.1440-1827.2007.02113_8.x
DO  - doi:10.1111/j.1440-1827.2007.02113_8.x
SP  - A23
EP  - A24
PY  - 2007
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - Neurogastroenterology & Motility
JA  - Neurogastroenterol. Motil.
VL  - 26
IS  - s1
SN  - 1350-1925
UR  - https://doi.org/10.1111/nmo.12412
DO  - doi:10.1111/nmo.12412
SP  - 11
EP  - 82
PY  - 2014
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Immunology
JA  - Immunology
VL  - 140
IS  - s1
SN  - 0019-2805
UR  - https://doi.org/10.1111/imm.12184
DO  - doi:10.1111/imm.12184
SP  - 39
EP  - 184
PY  - 2013
ER  - 

TY  - JOUR
TI  - Breast Pathology (7–19)
JO  - Pathology International
VL  - 57
IS  - s1
SN  - 1320-5463
UR  - https://doi.org/10.1111/j.1440-1827.2007.02113_2.x
DO  - doi:10.1111/j.1440-1827.2007.02113_2.x
SP  - A2
EP  - A6
PY  - 2007
ER  - 

TY  - JOUR
TI  - Gastrointestinal Pathology (37–57)
JO  - Pathology International
VL  - 57
IS  - s1
SN  - 1320-5463
UR  - https://doi.org/10.1111/j.1440-1827.2007.02113_5.x
DO  - doi:10.1111/j.1440-1827.2007.02113_5.x
SP  - A11
EP  - A17
PY  - 2007
ER  - 

TY  - JOUR
TI  - Infectious Diseases (83–84)
JO  - Pathology International
VL  - 57
IS  - s1
SN  - 1320-5463
UR  - https://doi.org/10.1111/j.1440-1827.2007.02113_9.x
DO  - doi:10.1111/j.1440-1827.2007.02113_9.x
SP  - A24
EP  - A25
PY  - 2007
ER  - 

TY  - JOUR
AU  - Sharma, Mukut
AU  - Halligan, Brian D.
AU  - Wakim, Bassam T.
AU  - Savin, Virginia J.
AU  - Cohen, Eric P.
AU  - Moulder, John E.
TI  - The urine proteome as a biomarker of radiation injury
JO  - PROTEOMICS – Clinical Applications
JA  - Prot. Clin. Appl.
VL  - 2
IS  - 7‐8
SN  - 1862-8346
UR  - https://doi.org/10.1002/prca.200780153
DO  - doi:10.1002/prca.200780153
SP  - 1065
EP  - 1086
KW  - Biomarkers
KW  - Nuclear accidents
KW  - Radiation injury
KW  - Radiological terrorism
KW  - Urine proteome
PY  - 2008
AB  - Abstract Terrorist attacks or nuclear accidents could expose large numbers of people to ionizing radiation, and early biomarkers of radiation injury would be critical for triage, treatment, and follow-up of such individuals. However, no such biomarkers have yet been proven to exist. We tested the potential of high throughput proteomics to identify protein biomarkers of radiation injury after total body X-ray irradiation (TBI) in a rat model. Subtle functional changes in the kidney are suggested by increased glomerular permeability for macromolecules measured within 24?h after TBI. Ultrastructural changes in glomerular podocytes included partial loss of the interdigitating organization of foot processes. Analysis of urine by LC-MS/MS and 2-DE showed significant changes in the urine proteome within 24?h after TBI. Tissue kallikrein 1-related peptidase, cysteine proteinase inhibitor cystatin C and oxidized histidine were found to be increased while a number of proteinase inhibitors including kallikrein-binding protein and albumin were found to be decreased postirradiation. Thus, TBI causes immediately detectable changes in renal structure and function and in the urinary protein profile. This suggests that both systemic and renal changes are induced by radiation and it may be possible to identify a set of biomarkers unique to radiation injury.
ER  - 

TY  - JOUR
TI  - ASGBI abstracts 2009 Poster presentations
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 96
IS  - S4
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.6641
DO  - doi:10.1002/bjs.6641
SP  - 82
EP  - 182
PY  - 2009
AB  - Abstract The Annual Scientific Meeting of the Association of Surgeons of Great Britain and Ireland takes place this year at the Scottish Exhibition and Conference Centre, Glasgow, UK (13th?15th May 2009), under the presidency of Professor Michael Horrocks. To view the abstracts from this meeting, please click the pdf link on this page. Copyright ? 2009 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
ER  - 

TY  - JOUR
TI  - Others (91–111)
JO  - Pathology International
VL  - 57
IS  - s1
SN  - 1320-5463
UR  - https://doi.org/10.1111/j.1440-1827.2007.02113_12.x
DO  - doi:10.1111/j.1440-1827.2007.02113_12.x
SP  - A27
EP  - A33
PY  - 2007
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - Colorectal Disease
VL  - 11
IS  - s1
SN  - 1462-8910
UR  - https://doi.org/10.1111/j.1463-1318.2009.01851.x
DO  - doi:10.1111/j.1463-1318.2009.01851.x
SP  - 1
EP  - 13
PY  - 2009
ER  - 

TY  - JOUR
TI  - Molecular Pathology (85–89)
JO  - Pathology International
VL  - 57
IS  - s1
SN  - 1320-5463
UR  - https://doi.org/10.1111/j.1440-1827.2007.02113_10.x
DO  - doi:10.1111/j.1440-1827.2007.02113_10.x
SP  - A25
EP  - A26
PY  - 2007
ER  - 

TY  - JOUR
TI  - Pulmonary Pathology (112–116)
JO  - Pathology International
VL  - 57
IS  - s1
SN  - 1320-5463
UR  - https://doi.org/10.1111/j.1440-1827.2007.02113_13.x
DO  - doi:10.1111/j.1440-1827.2007.02113_13.x
SP  - A33
EP  - A35
PY  - 2007
ER  - 
